4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Validation of a Point-of-Care Optical Coherence Tomography Device with Machine Learning Algorithm for Detection of Oral Potentially Malignant and Malignant Lesions

      research-article
      1 , 2 , 1 , 2 , 3 , 4 , 1 , 4 , 4 , 5 , 5 , 6 , 6 , 3 , 3 , 3 , 7 , 7 , 4 , 8 , 5 , 5 , 1 , 5 , 6 , 4 , 1 , 3 , * , 1 , 3 , *
      , ,
      Cancers
      MDPI
      optical coherence tomography, oral cancer, oral squamous cell carcinoma, oral potentially malignant lesions, pre-malignant lesions, artificial neural network

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Simple Summary

          Early detection is crucial towards improving survival in patients diagnosed with oral cancer. Non-invasive strategies equivalent to histology diagnosis are extremely valuable in oral cancer screening and early detection in resource-constrained settings. Optical coherence tomography (OCT), an optical biopsy technique enables real-time imaging with periodic surveillance and capability to image architectural features of the tissues. We report that while OCT system delineates oral pre-cancer and cancer with more than 90% sensitivity, integration, with artificial neural network-based analysis efficiently identifies high-risk, oral pre-cancer (83%). This study provides evidence that the robust, low-cost system was effective as a point-of-care device in resource-constrained settings. The high accuracy and portability signify widespread clinical application in oral cancer screening and/or surveillance.

          Abstract

          Non-invasive strategies that can identify oral malignant and dysplastic oral potentially-malignant lesions (OPML) are necessary in cancer screening and long-term surveillance. Optical coherence tomography (OCT) can be a rapid, real time and non-invasive imaging method for frequent patient surveillance. Here, we report the validation of a portable, robust OCT device in 232 patients (lesions: 347) in different clinical settings. The device deployed with algorithm-based automated diagnosis, showed efficacy in delineation of oral benign and normal ( n = 151), OPML ( n = 121), and malignant lesions ( n = 75) in community and tertiary care settings. This study showed that OCT images analyzed by automated image processing algorithm could distinguish the dysplastic-OPML and malignant lesions with a sensitivity of 95% and 93%, respectively. Furthermore, we explored the ability of multiple ( n = 14) artificial neural network (ANN) based feature extraction techniques for delineation high grade-OPML (moderate/severe dysplasia). The support vector machine (SVM) model built over ANN, delineated high-grade dysplasia with sensitivity of 83%, which in turn, can be employed to triage patients for tertiary care. The study provides evidence towards the utility of the robust and low-cost OCT instrument as a point-of-care device in resource-constrained settings and the potential clinical application of device in screening and surveillance of oral cancer.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

          This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sample size estimation in diagnostic test studies of biomedical informatics.

            This review provided a conceptual framework of sample size calculations in the studies of diagnostic test accuracy in various conditions and test outcomes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial.

              Oral cancer is common in men from developing countries, and is increased by tobacco and alcohol use. We aimed to assess the effect of visual screening on oral cancer mortality in a cluster-randomised controlled trial in India. Of the 13 clusters chosen for the study, seven were randomised to three rounds of oral visual inspection by trained health workers at 3-year intervals and six to a control group during 1996-2004, in Trivandrum district, Kerala, India. Healthy participants aged 35 years and older were eligible for the study. Screen-positive people were referred for clinical examination by doctors, biopsy, and treatment. Outcome measures were survival, case fatality, and oral cancer mortality. Oral cancer mortality in the study groups was analysed and compared by use of cluster analysis. Analysis was by intention to treat. Of the 96,517 eligible participants in the intervention group, 87,655 (91%) were screened at least once, 53,312 (55%) twice, and 29,102 (30%) three times. Of the 5145 individuals who screened positive, 3218 (63%) complied with referral. 95,356 eligible participants in the control group received standard care. 205 oral cancer cases and 77 oral cancer deaths were recorded in the intervention group compared with 158 cases and 87 deaths in the control group (mortality rate ratio 0.79 [95% CI 0.51-1.22]). 70 oral cancer deaths took place in users of tobacco or alcohol, or both, in the intervention group, compared with 85 in controls (0.66 [0.45-0.95]). The mortality rate ratio was 0.57 (0.35-0.93) in male tobacco or alcohol users and 0.78 (0.43-1.42) in female users. : Oral visual screening can reduce mortality in high-risk individuals and has the potential of preventing at least 37,000 oral cancer deaths worldwide.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Role: Academic Editor
                Role: Academic Editor
                Journal
                Cancers (Basel)
                Cancers (Basel)
                cancers
                Cancers
                MDPI
                2072-6694
                17 July 2021
                July 2021
                : 13
                : 14
                : 3583
                Affiliations
                [1 ]Integrated Head and Neck Oncology Program (DSRG-5), Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India; bonney.lee.james@ 123456ms-mf.org (B.L.J.); sumsumsp@ 123456gmail.com (S.P.S.); ravindradr88@ 123456gmail.com (R.D.R.); praveen.birur@ 123456gmail.com (P.B.N.)
                [2 ]Manipal Academy of Higher Education (MAHE), Karnataka 576104, India
                [3 ]Department of Head and Neck Oncology, Mazumdar Shaw Medical Center, NH Health City, Bangalore 560099, India; drvijaypillai@ 123456gmail.com (V.P.); vivek.shetty.dr@ 123456narayanahealth.org (V.S.); hednenaveen@ 123456gmail.com (N.H.)
                [4 ]Beckman Laser Institute, UCI, Irvine, CA 92612, USA; aheidari.uci@ 123456gmail.com (A.E.H.); tracielam.m@ 123456gmail.com (T.L.); annevt@ 123456uci.edu (A.V.T.); z2chen@ 123456uci.edu (Z.-p.C.); pwsmith@ 123456uci.edu (P.W.-S.)
                [5 ]Department of Oral Medicine and Radiology, KLE Society’s Institute of Dental Sciences, Bangalore 560022, India; kankanala.sandeep86@ 123456gmail.com (S.K.); shiladitya.sil@ 123456gmail.com (S.S.); subhashiniar@ 123456gmail.com (S.A.R.); drshubha.gurudath@ 123456gmail.com (S.G.)
                [6 ]Biocon Foundation, Bangalore 560100, India; vidyatiwari96@ 123456gmail.com (V.T.); tanjupat@ 123456yahoo.com (S.P.)
                [7 ]Mazumdar Shaw Center for Translational Research (MSCTR), Mazumdar Shaw Medical Foundation, NH Health City, Bangalore 560099, India; dshahms@ 123456hotmail.com (D.S.); nameeta.shah@ 123456ms-mf.org (N.S.)
                [8 ]Department of Oral and Maxillofacial Pathology, KLE Society’s Institute of Dental Sciences, Bangalore 560022, India; umak235@ 123456gmail.com
                Author notes
                [†]

                Contributed Equally.

                Author information
                https://orcid.org/0000-0003-2131-1126
                https://orcid.org/0000-0002-3923-9348
                https://orcid.org/0000-0002-9171-7319
                Article
                cancers-13-03583
                10.3390/cancers13143583
                8304149
                34298796
                2ef64c9b-e331-4e62-9325-b909942cbc46
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 22 April 2021
                : 04 June 2021
                Categories
                Article

                optical coherence tomography,oral cancer,oral squamous cell carcinoma,oral potentially malignant lesions,pre-malignant lesions,artificial neural network

                Comments

                Comment on this article